Verdence Capital Advisors LLC Sarepta Therapeutics, Inc. Transaction History

Verdence Capital Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 24, 2023	BUY	$117.53 - $155.99 $117 - $155	1 Added 0.03%	3,651 $503,000
Q4 2021 Jan 26, 2022	SELL	$77.28 - $99.42 $10,819 - $13,918	-140 Reduced 3.69%	3,650 $329,000
Q3 2021 Nov 12, 2021	SELL	$65.97 - $92.48 $106,211 - $148,892	-1,610 Reduced 29.81%	3,790 $350,000
Q2 2021 Aug 06, 2021	BUY	$69.38 - $86.75 $97,132 - $121,450	1,400 Added 35.0%	5,400 $420,000
Q1 2021 May 11, 2021	BUY	$72.25 - $168.95 $3,612 - $8,447	50 Added 1.27%	4,000 $298,000
Q4 2020 Feb 12, 2021	SELL	$125.56 - $178.74 $439,460 - $625,590	-3,500 Reduced 46.98%	3,950 $673,000
Q3 2020 Nov 09, 2020	BUY	$127.12 - $172.34 $947,044 - $1.28 Million	7,450 New	7,450 $1.05 Million

528

85M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.79B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Verdence Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Verdence Capital Advisors LLC with notifications on news.